BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36515250)

  • 1. In-Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample.
    Wu J; Fan Y; Zhao W; Li B; Pan N; Lou Z; Zhang M
    J Am Heart Assoc; 2022 Dec; 11(24):e027352. PubMed ID: 36515250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Management and In-Hospital Outcomes of Myocardial Infarction Patients in United States Safety-Net Hospitals.
    Bashar H; Bharadwaj A; Matetić A; Ullah W; Beasley DL; Bullock-Palmer RP; Curzen N; Mamas MA
    Cardiovasc Revasc Med; 2023 Apr; 49():7-12. PubMed ID: 36411236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline-Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes.
    Suzuki T; Kataoka Y; Shiozawa M; Morris K; Kiyoshige E; Nishimura K; Murai K; Sawada K; Iwai T; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Koga M; Ihara M; Toyoda K; Tsujita K; Noguchi T
    J Am Heart Assoc; 2023 Jan; 12(2):e027156. PubMed ID: 36645078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.
    Sagheer S; Deka P; Pathak D; Khan U; Zaidi SH; Akhlaq A; Blankenship J; Annis A
    Curr Probl Cardiol; 2022 Nov; 47(11):101086. PubMed ID: 34936910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Myocardial Infarction in Severe Mental Illness: Prevalence, Clinical Outcomes, and Process of Care in U.S. Hospitalizations.
    Mohamed MO; Rashid M; Farooq S; Siddiqui N; Parwani P; Shiers D; Thamman R; Gulati M; Shoaib A; Chew-Graham C; Mamas MA
    Can J Cardiol; 2019 Jul; 35(7):821-830. PubMed ID: 31292080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction.
    Smilowitz NR; Gupta N; Guo Y; Bangalore S
    Am J Cardiol; 2016 Apr; 117(7):1065-71. PubMed ID: 26853952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Diabetes Mellitus and Its Types with In-Hospital Management and Outcomes of Patients with Acute Myocardial Infarction.
    Sethupathi P; Matetić A; Bang V; Myint PK; Rendon I; Bagur R; Diaz-Arocutipa C; Ricalde A; Bharadwaj A; Mamas MA
    Cardiovasc Revasc Med; 2023 Jul; 52():16-22. PubMed ID: 36854639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
    Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
    Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between in-hospital event rates and high bleeding risk score in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Tsukizawa T; Fujihara M
    Cardiovasc Interv Ther; 2022 Jul; 37(3):490-496. PubMed ID: 34406605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
    Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
    J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Assessment of Major Adverse Cardiovascular and Cerebrovascular Events and Bleeding for Acute Myocardial Infarction With or Without Active Tuberculosis.
    Xu X; Zhu H; Cai L; Liu L; Zhang F; Zhou H; Mei B; Zhu M; Dai L; Chen T; Xu K
    Clin Ther; 2022 Oct; 44(10):1370-1379. PubMed ID: 36150925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative acute myocardial infarction associated with non-cardiac surgery.
    Smilowitz NR; Gupta N; Guo Y; Berger JS; Bangalore S
    Eur Heart J; 2017 Aug; 38(31):2409-2417. PubMed ID: 28821166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia.
    Pemmaraju N; Gerds AT; Yu J; Parasuraman S; Shah A; Xi A; Kumar S; Scherber RM; Verstovsek S
    Leuk Res; 2022 Apr; 115():106809. PubMed ID: 35220060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
    Gluckman TJ; Wilson MA; Chiu ST; Penny BW; Chepuri VB; Waggoner JW; Spinelli KJ
    JAMA Cardiol; 2020 Dec; 5(12):1419-1424. PubMed ID: 32766756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute coronary disease in essential thrombocythemia and polycythemia vera.
    Rossi C; Randi ML; Zerbinati P; Rinaldi V; Girolami A
    J Intern Med; 1998 Jul; 244(1):49-53. PubMed ID: 9698024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.
    Pósfai É; Marton I; Borbényi Z; Nemes A
    Anatol J Cardiol; 2016 Jun; 16(6):397-402. PubMed ID: 27182615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.